Dr. Goldsby is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
550 16th St
# 434
San Francisco, CA 94143Phone+1 415-476-3831Fax+1 415-502-4372- Is this information wrong?
Summary
- Dr. Robert Goldsby, located in San Francisco, specializes in Pediatric Hematology and Oncology. He completed his Residency in Pediatrics at Children's Hospital-Oakland and a Fellowship in Pediatric Hematology/Oncology at the University of Utah Health. Currently a Professor at UCSF Medical Center, he also actively contributes to the medical field with numerous publications. His works have been recognized and cited multiple times by fellow researchers. Dr. Goldsby additionally participates in several clinical trials, including the treatment strategies for osteosarcoma, lymphomas, and liver cancer in young patients, showcasing his active role in advancing treatment for childhood cancers.
Education & Training
- University of Utah HealthFellowship, Pediatric Hematology/Oncology, 1994 - 1997
- Children's Hospital-OaklandResidency, Pediatrics, 1991 - 1994
- University of Vermont College of MedicineClass of 1991
Certifications & Licensure
- CA State Medical License 2002 - 2025
- UT State Medical License 1994 - 2004
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 18
- 131 I-MIBG in Treating Patients With Refractory or Relapsed Neuroblastoma Start of enrollment: 2005 Apr 01
- Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies Start of enrollment: 2008 Jul 17
- Join now to see all
Publications & Presentations
PubMed
- 5 citationsWhat Are Risk Factors for and Outcomes of Late Amputation After Treatment for Lower Extremity Sarcoma: A Childhood Cancer Survivor Study Report.Erik J Geiger, Wei Liu, Deo Kumar Srivastava, Nicholas M Bernthal, Brent R Weil, Yutaka Yasui, Kirsten K Ness, Kevin R Krull, Robert E Goldsby, Kevin C Oeffinger, Lesl...> ;Clinical Orthopaedics and Related Research. 2023 Mar 1
- 4 citationsDay-to-Day Decision Making by Adolescents and Young Adults with Cancer.Kimberly A Pyke-Grimm, Linda S Franck, Bonnie Halpern-Felsher, Robert E Goldsby, Roberta S Rehm> ;Journal of Pediatric Hematology/oncology Nursing. 2022 Jan 15
- 16 citationsLate-onset kidney failure in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.Bryan V. Dieffenbach, Qi Liu, Andrew J. Murphy, Deborah R. Stein, Natalie Wu, Arin L. Madenci, Wendy M. Leisenring, Nina S. Kadan-Lottick, Emily R. Christison-Lagay, R...> ;European Journal of Cancer. 2021 Sep 1
- Join now to see all
Press Mentions
- Special Notice Concerning COVID-19February 9th, 2021
- Researchers, Physicians Caution Against Use of Solitary Confinement to Prevent COVID-19 Spread in PrisonsJuly 14th, 2020
- Childhood Cancer Burden Much Bigger Than Previously RecognizedJuly 28th, 2019
- Join now to see all
Grant Support
- Polymerase Proofreading And MutagenesisNational Cancer Institute1997–2001
Hospital Affiliations
- UCSF Medical CenterSan Francisco, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: